前列腺集团检查对诊断前列腺癌的临床价值  

Clinical Value of Examination in the Diagnosis of Prostate Carcinoma

作　　者：周振星[1] 徐勋[1] 胡明[1] 

机构地区：[1]南方医科大学附属南海人民医院泌尿外科,广东佛山528000

出　　处：《河北医学》2009年第2期208-210,共3页Hebei Medicine

摘　　要：目的:提高前列腺癌的诊断水平。方法:对2000例中老年男性(≥40岁)门诊及住院病人,以及社区人员常规进行前列腺指检、血PSA检查及经直肠前列腺B超检查,活检筛选出前列腺癌15例(0.75%),将病人分组进行比较。结果:≥70岁及PSA≥4ng/ml组患者前列腺癌发生率明显高于其余各组(P<0.05)。结论:PSA联合直肠指检及经直肠前列腺B超检查是目前筛选前列腺癌最简便而又最重要的指标。Abstract： Objective： To review the diagnosis of prostate carcinoma. Method： Digital rectal examination （ DRE ）, prostatic specific antigen （ PSA ） and transrectal ultrasonography （ TRUS ） were studied in 2000 males over 40 years of age. Biopsy was carried out when needed. 15 prostate carcinoma （ 0.75% ） were found out of 2000 as verified on biopsy. Result： The males of over 70 years of age and PSA above 4ng/ml were very higher in the carcinoma group （ P 〈 0.05 ）. Conclusion： PSA assay, DRE and TRUS arc the most important and simple means to discover prostate carcinoma.

关 键 词：前列腺癌 前列腺特异抗原 直肠指检 经直肠前列腺B超 

分 类 号：R737.25[医药卫生—肿瘤]